Investigating a novel mechanism for suppressing hepatic steatosis in NAFLD.

For the best experience of St Vincent Institute website, please view this site in either Microsoft Edge, Google Chrome, Safari internet browsers rather than Internet Explorer.

We aim to investigate whether pharmacological inhibition of SIKs signalling will promote weight loss in obesity.

Supervised by

Disease focus

Type 2 diabetes